EUVIMED · CrossrefJournal
Expert Review of Hematology
ISSN 1747-4086 · Informa UK Limited
Latest articles
Real-world hematocrit control, burden of phlebotomy, and quality of life in patients with polycythemia vera treated with phlebotomy in the United States: results from a real-world survey
Self-administered therapies in paroxysmal nocturnal hemoglobinuria: balancing quality of life with clinically relevant risks
Challenges in monitoring factor VIII activity during hemophilia a treatment: toward individualized monitoring strategies
Impact of inhibitors on treatment patterns and disease burden in Chinese patients with hemophilia: a cross-sectional study
Guided precision management of iTTP: optimizing treatment, monitoring, and relapse prevention
Managing poor graft function after stem cell transplantation
Risk of red blood cell transfusion in patients with preoperative anemia requiring cardiac surgery
Managing acute graft-versus-host disease after allogeneic stem cell transplantation
Complete remission in older acute myeloid leukemia: when does it really matter?
The evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis
Progression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?
Treatment of older adults with newly diagnosed FLT3 -mutated AML: focus on lower-intensity triplet regimens
Shear wave elastography as a screening modality for liver fibrosis in a comprehensive sickle cell disease clinic
Managing thrombotic risk in myeloproliferative disorders
Implementation barriers of standardizing flow cytometric immune reconstitution monitoring post-allogeneic hematopoietic cell transplantation
Resistance mechanisms and therapeutic strategies after menin inhibitor failure in acute myeloid leukemia
Adaptations in pacritinib usage for myelofibrosis and thrombocytopenia since FDA approval
Rising myeloproliferative neoplasms in younger patients: preserving future fertility and pregnancies
Immunoglobulins as replacement therapy in hematological malignancies: from historical hypogammaglobulinemia to the era of T-cell-engaging therapies
Reframing sickle cell disease care: improving care with an embedded primary care model for chronic comorbidity management
Utilizing evidence-based diagnosis and treatment for central venous thrombosis: closing the gaps where guidelines fail
Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment
Diagnostic challenges in light chain (AL) amyloidosis for high-risk patients
Embedding cardiovascular risk assessment into routine BTK inhibitor management in chronic lymphocytic leukemia
Leukapheresis versus no leukapheresis for hyperleukocytosis in acute myeloid leukemia: an updated systematic review and meta-analysis of early mortality
Expression and prognostic value of cytotoxic T-lymphocyte-associated 4 protein in classic Hodgkin lymphoma
Primary diffuse large B-cell lymphoma in the era of targeted therapies: incidence, second primary malignancy and prognosis
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma
Autoimmune cytopenias in chronic lymphocytic leukemia in the era of novel drugs
Barriers to effective first-line treatment for women with iron deficiency
EUVIMED